Furthermore, we confirmed LINC00467 as a tumor promoter in vitro and predicted the mechanism of LINC00467 dysexpression as well as its regulation of downstream signaling pathways based on bioinformatics analysis, providing a new insight for the development of biomarkers and therapeutic targets for BRCA. This evidence concerns the gene LINC00467 and neoplasm.